Susquehanna International Group’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-110,200
Closed -$644K 14051
2025
Q1
$644K Buy
+110,200
New +$581K ﹤0.01% 8346
2024
Q4
Sell
-13,600
Closed -$76K 13489
2024
Q3
$76K Buy
13,600
+100
+0.7% +$700 ﹤0.01% 11196
2024
Q2
$114K Sell
13,500
-12,900
-49% -$138K ﹤0.01% 10925
2024
Q1
$381K Sell
26,400
-60,300
-70% -$997K ﹤0.01% 9138
2023
Q4
$1.87M Buy
86,700
+55,000
+174% +$981K ﹤0.01% 5511
2023
Q3
$609K Buy
31,700
+9,400
+42% +$200K ﹤0.01% 7764
2023
Q2
$567K Sell
22,300
-14,200
-39% -$410K ﹤0.01% 8019
2023
Q1
$1.32M Sell
36,500
-3,000
-8% -$105K ﹤0.01% 6119
2022
Q4
$1.56M Sell
39,500
-40,700
-51% -$1.69M ﹤0.01% 5191
2022
Q3
$3.74M Buy
80,200
+19,300
+32% +$896K ﹤0.01% 3654
2022
Q2
$2.67M Sell
60,900
-13,200
-18% -$726K ﹤0.01% 4290
2022
Q1
$5.36M Buy
74,100
+35,100
+90% +$2.53M ﹤0.01% 3523
2021
Q4
$3.16M Buy
39,000
+11,200
+40% +$1.12M ﹤0.01% 4556
2021
Q3
$3.23M Buy
27,800
+6,700
+32% +$877K ﹤0.01% 4795
2021
Q2
$3.5M Buy
21,100
+3,500
+20% +$546K ﹤0.01% 4708
2021
Q1
$2.46M Sell
17,600
-15,900
-47% -$2.59M ﹤0.01% 5416
2020
Q4
$5.8M Sell
33,500
-39,800
-54% -$6.45M ﹤0.01% 3201
2020
Q3
$10.2M Sell
73,300
-25,300
-26% -$3.38M ﹤0.01% 2143
2020
Q2
$11.8M Sell
98,600
-73,700
-43% -$8.74M ﹤0.01% 1951
2020
Q1
$17.2M Buy
172,300
+71,500
+71% +$8.6M 0.01% 1285
2019
Q4
$11.8M Buy
100,800
+62,300
+162% +$6.17M ﹤0.01% 1900
2019
Q3
$3.31M Buy
38,500
+500
+1% +$37.8K ﹤0.01% 3335
2019
Q2
$2.46M Sell
38,000
-112,400
-75% -$7M ﹤0.01% 3769
2019
Q1
$9.4M Sell
150,400
-185,900
-55% -$8.74M ﹤0.01% 1794
2018
Q4
$13.1M Buy
336,300
+281,900
+518% +$12.5M 0.01% 1376
2018
Q3
$3.1M Buy
54,400
+12,500
+30% +$781K ﹤0.01% 3320
2018
Q2
$3.35M Sell
41,900
-82,400
-66% -$6.84M ﹤0.01% 3246
2018
Q1
$10.8M Buy
124,300
+40,400
+48% +$3.26M ﹤0.01% 1712
2017
Q4
$5.79M Sell
83,900
-105,100
-56% -$8.41M ﹤0.01% 2374
2017
Q3
$17.2M Buy
189,000
+154,900
+454% +$13.3M 0.01% 1334
2017
Q2
$2.54M Sell
34,100
-53,700
-61% -$4.3M ﹤0.01% 3457
2017
Q1
$8.23M Sell
87,800
-37,100
-30% -$3.36M ﹤0.01% 1817
2016
Q4
$9.07M Buy
124,900
+58,300
+88% +$4.99M ﹤0.01% 1655
2016
Q3
$6.95M Sell
66,600
-76,400
-53% -$6.9M ﹤0.01% 1868
2016
Q2
$10.5M Buy
143,000
+106,800
+295% +$7.25M 0.01% 1414
2016
Q1
$2.04M Buy
36,200
+27,100
+298% +$1.6M ﹤0.01% 3727
2015
Q4
$614K Sell
9,100
-10,200
-53% -$546K ﹤0.01% 6371
2015
Q3
$895K Buy
19,300
+4,300
+29% +$208K ﹤0.01% 5993
2015
Q2
$806K Buy
+15,000
New +$764K ﹤0.01% 6654

Other funds holding NVRO

Susquehanna International Group's NVRO Position: Q2 2025 in Review

Susquehanna International Group sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 76,479 shares — an estimated $447K sold.

Susquehanna International Group first reported a position in NVRO in Q4 2014 and held it in 30 quarters. The position peaked at $5.19M in Q1 2023. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Susquehanna International Group reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 76,479 NEVRO CORP. shares in Q2 2025, an estimated $447K.
  • Susquehanna International Group first reported a position in NEVRO CORP. in Q4 2014 and held it in 30 quarters.
  • Susquehanna International Group's NEVRO CORP. position peaked at $5.19M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.